EagleBio/α-突触核蛋白预制原纤维(1型)/SPR-322

价格
面议
货号:SPR-322
浏览量:127
品牌:EagleBio
服务
全国联保
正品保证
正规发票
签订合同
商品描述

Alpha Synuclein Preformed Fibrils (Type 1)

The Alpha Synuclein Preformed Fibrils (Type 1) is For Research Use Only

Specificity: ~14.46 kDa
Species: Human
Expression System: E. coli
Buffer: PBS
Storage Temperature: -80ºC

Product manufactured in Canada by StressMarq.


Alternative Names
Active Human Recombinant Alpha Synuclein Preformed Fibrils (Type 1), Active Alpha synuclein PFFs, Active Alpha synuclein aggregates, Active Alpha synuclein protein aggregates, Active Alpha synuclein aggregates, Active Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, SYN protein, Parkinson disease familial 1 Protein, Active Alpha synuclein protein seed


Assay Background

Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals. Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus. Functionally, it has been shown to significantly interact with tubulin, and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions; inactivation may lead to impaired spatial learning and working memory. SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson’s disease. Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin.


Related Products

Alpha Synuclein Preformed Fibrils (Type 2)
Alpha Synuclein Protein Monomer (Type 1)
Alpha Synuclein Protein Monomer (Type 2)

EagleBio的iLite®分析就绪细胞iLite®  技术基于报告基因检测格式,经过修改和适用于整个药物开发周期中的应用以及生物药物的监测。这些细胞系可以开发用于任何生物制药靶标,并且可以使用相同的细胞系轻松设置药物效力(即药物活性)的测定方法。检验就绪的细胞经过基因工程处理,可与报告基因检验技术一起使用,以检测药物效力和NAb。